Recursion Pharmaceuticals Inc (RXRX)
6.91
-0.41
(-5.60%)
USD |
NASDAQ |
Nov 14, 16:00
6.90
-0.01
(-0.14%)
After-Hours: 04:05
Recursion Pharmaceuticals Gross Profit (Annual): 1.289M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.289M |
| December 31, 2022 | -8.594M |
| Date | Value |
|---|---|
| December 31, 2021 | 10.00M |
| December 31, 2020 | 3.413M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-8.594M
Minimum
2022
10.00M
Maximum
2021
1.527M
Average
2.351M
Median
Gross Profit (Annual) Benchmarks
| Revance Therapeutics Inc | 159.68M |
| Eli Lilly and Co | 27.04B |
| Pfizer Inc | 33.54B |
| Twist Bioscience Corp | 89.73M |
| NovaBay Pharmaceuticals Inc | 7.895M |